Targeting the Calcineurin Homologous Protein 1 (CHP1)-Transmembrane Protein 87A (TMEM87A) mechanosensing complex: a druggable vulnerability in metastatic ovarian cancer

Ming-Zhu Jin, Heng-An Liu, Wen Di · 2026

Read Targeting the Calcineurin Homologous Protein 1 (CHP1)-Transmembrane Protein 87A (TMEM87A) mechanosensing complex: a druggable vulnerability in metastatic ovarian cancer by Ming-Zhu Jin, Heng-An Liu, Wen Di (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13247001.txt.

Description

Jin, Liu, Di, and co-authors identified a force-sensing protein pair that helps ovarian cancer spread, in this 2026 Molecular Biomedicine paper. High-grade serous ovarian cancer kills by scattering through the abdomen, which requires tumor cells to survive after detaching, a step many cancers fail. Searching gene data linked to tissue sugar metabolism, the team landed on a protein called CHP1 and its partner TMEM87A.

Removing either protein wrecked the tumor spheroids' structure in laboratory models and sharply reduced tumor growth and spread in mice, apparently by quieting a growth-signaling pathway. A repurposed compound, sodium gluconate, broke the pair apart and shrank tumors at low doses without obvious organ damage. The authors propose the complex as a druggable weak point in metastatic disease.

Catalog record

CREATORMing-Zhu Jin, Heng-An Liu, Wen Di
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13247001

Browse the full library · About the Tower of Babel